ZEB1 and nasopharyngeal carcinoma: miR-429 was shown to be expressed at low levels in metastatic lesions of NPC patients and to inhibit proliferation, invasion and migration of some NPC cell lines by targeting zinc finger E-box-binding homeobox 1 (ZEB1) and CRK-like (CRKL) protein expression [19, 41].